AI-based digital MammaPrint assay predicts recurrence risk and survival in early-stage breast cancer

AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

Harnessing AI and data to predict, personalise and transform cancer care

Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors

Highlights from APCCC 2026

ASCO 2026: Updates in bladder cancer

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Favezelimab plus pembrolizumab improves progression-free survival in PD-1-refractory classic Hodgkin lymphoma

ASCO 2026: Comment: Multi-cancer earlier detection tests

Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours

miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumours

Challenges in high-risk NMIBC: Addressing current unmet needs to optimise patient care